Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value

Respiratory syncytial virus (RSV) infection is the most common cause of lower respiratory tract infection and the leading cause of hospitalization among young children, incurring high annual costs among US children under the age of 5 years. Palivizumab has been found to be effective in reducing hosp...

全面介紹

Na minha lista:
書目詳細資料
發表在:Open Forum Infect Dis
Main Authors: Olchanski, Natalia, Hansen, Ryan N, Pope, Elle, D’Cruz, Brittany, Fergie, Jaime, Goldstein, Mitchell, Krilov, Leonard R, McLaurin, Kimmie K, Nabrit-Stephens, Barbara, Oster, Gerald, Schaecher, Kenneth, Shaya, Fadia T, Neumann, Peter J, Sullivan, Sean D
格式: Artigo
語言:Inglês
出版: Oxford University Press 2018
主題:
Review Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833316/
https://ncbi.nlm.nih.gov/pubmed/29516023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy031
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍